{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:55:58Z","timestamp":1791575758991,"version":"4.3.4"},"reference-count":187,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T00:00:00Z","timestamp":1640131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003204","name":"Airbus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003204","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Current risk stratification strategies for coronary artery disease (CAD) have low predictive value in asymptomatic subjects classified as intermediate cardiovascular risk. This is relevant because not all coronary events occur in individuals with traditional multiple risk factors. Most importantly, the first manifestation of the disease may be either sudden cardiac death or acute coronary syndrome, after rupture and thrombosis of an unstable non-obstructive atherosclerotic plaque, which was previously silent. The inaccurate stratification using the current models may ultimately subject the individual to excessive or insufficient preventive therapies. A breakthrough in the comprehension of the molecular mechanisms governing the atherosclerosis pathology has driven many researches toward the necessity for a better risk stratification. In this Review, we discuss how metabolomics screening integrated with traditional risk assessments becomes a powerful approach to improve non-invasive CAD subclinical diagnostics. In addition, this Review highlights the findings of metabolomics studies performed by two relevant analytical platforms in current use\u2013mass spectrometry (MS) hyphenated to separation techniques and nuclear magnetic resonance spectroscopy (NMR) \u2013and evaluates critically the challenges for further clinical implementation of metabolomics data. We also discuss the modern understanding of the pathophysiology of atherosclerosis and the limitations of traditional analytical methods. Our aim is to show how discriminant metabolites originated from metabolomics approaches may become promising candidate molecules to aid intermediate risk patient stratification for cardiovascular events and how these tools could successfully meet the demands to translate cardiovascular metabolic biomarkers into clinical settings.<\/jats:p>","DOI":"10.3389\/fcvm.2021.788062","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T08:00:25Z","timestamp":1640160025000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Innovative Approaches to Assess Intermediate Cardiovascular Risk Subjects: A Review From Clinical to Metabolomics Strategies"],"prefix":"10.3389","volume":"8","author":[{"given":"Aline M. A.","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana U. B.","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego V. N.","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphaela M.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique L.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo J. S. R.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina R. C.","family":"Picossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9a T.","family":"Faccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina F. M.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coral","family":"Barbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane Z. R.","family":"Giraldez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul D.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme U.","family":"Monte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando A.","family":"Atik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur J Prev Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.113.004042","article-title":"Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010","volume":"129","author":"Moran","year":"2014","journal-title":"Circulation."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1161\/CIR.0000000000000350","article-title":"Heart disease and stroke statistics \u2014 2016 update","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation."},{"key":"B4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrcardio.2016.101","article-title":"Precision medicine in cardiology","volume":"13","author":"Antman","year":"2016","journal-title":"Nat Rev Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1161\/CIR.0000000000000725","article-title":"2019 ACC\/AHA Guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation."},{"key":"B6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/heartjnl-2019-316006","article-title":"Acute coronary syndromes: a success story but still a long way to go [editorial]","volume":"106","author":"Shaw","year":"2020","journal-title":"Heart."},{"key":"B7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.7326\/M14-1281","article-title":"An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort","volume":"162","author":"DeFilippis","year":"2015","journal-title":"Ann Intern Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/jama.2018.4242","article-title":"Nontraditional risk factors in cardiovascular disease risk assessment","volume":"320","author":"Lin","year":"2018","journal-title":"JAMA."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1093\/eurheartj\/ehv236","article-title":"Novel methodologies for biomarker discovery in atherosclerosis","volume":"36","author":"Hoefer","year":"2015","journal-title":"Eur Heart J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/HPC.0000000000000045","article-title":"Agreement between cardiovascular disease risk scores in resource-limited settings","volume":"14","author":"Bazo-Alvarez","year":"2015","journal-title":"Crit Pathw Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.109.849166","article-title":"Cardiovascular risk prediction","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1161\/hc4201.097189","article-title":"Improving coronary heart disease risk assessment in asymptomatic people","volume":"104","author":"Greenland","year":"2001","journal-title":"Circulation."},{"key":"B13","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/clc.22930","article-title":"The art of cardiovascular risk assessment","volume":"41","author":"Khambhati","year":"2018","journal-title":"Clin Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2012.9624","article-title":"Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals","volume":"308","author":"Yeboah","year":"2012","journal-title":"JAMA."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1016\/j.jacc.2018.11.005","article-title":"Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease","volume":"73","author":"Lloyd-Jones","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Prim."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation."},{"key":"B18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/eurheartj\/ehw599","article-title":"Superficial erosion and the precision management of acute coronary syndromes: not one-size-fits-all [editorial]","volume":"38","author":"Libby","year":"2017","journal-title":"Eur Heart J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jacc.2009.09.007","article-title":"Relationship of thrombus healing to underlying plaque morphology in sudden coronary death","volume":"55","author":"Kramer","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature."},{"key":"B22","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1093\/ehjci\/jeu033","article-title":"Plasma lipidomic analysis predicts non-calcified coronary artery plaque in asymptomatic patients at intermediate risk of coronary artery disease","volume":"15","author":"Ellims","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B23","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jacc.2011.02.074","article-title":"Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings","volume":"58","author":"Min","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2967\/jnumed.116.187906","article-title":"Molecular imaging of vulnerable coronary plaque: a pathophysiologic perspective","volume":"58","author":"Krishnan","year":"2017","journal-title":"J Nucl Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.jacc.2009.12.027","article-title":"The year in atherothrombosis","volume":"55","author":"Sanz","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jacc.2017.12.006","article-title":"Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke","volume":"71","author":"Holmes M","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1161\/01.CIR.0000118498.35499.B2","article-title":"Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000","volume":"109","author":"Unal","year":"2004","journal-title":"Circulation."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e106455","DOI":"10.1371\/journal.pone.0106455","article-title":"Prediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk?","volume":"9","author":"van Staa","year":"2014","journal-title":"PLoS ONE."},{"key":"B29","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/eurheartj\/ehw301","article-title":"Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort","volume":"38","author":"DeFilippis","year":"2016","journal-title":"Eur Heart J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1056\/NEJMoa0907272","article-title":"Low diagnostic yield of elective coronary angiography","volume":"362","author":"Patel","year":"2010","journal-title":"N Engl J Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/eurheartj\/ehs473","article-title":"Discordance between Framingham Risk Score and atherosclerotic plaque burden","volume":"34","author":"Pen","year":"2013","journal-title":"Eur Heart J."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European guidelines on cardiovascular disease prevention in clinical practice","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1016\/S0735-1097(03)00358-9","article-title":"Task force #1 \u2014 identification of coronary heart disease risk: is there a detection gap?","volume":"41","author":"Pasternak","year":"2003","journal-title":"J Am Coll Cardiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.amjcard.2008.03.058","article-title":"Association of coronary atherosclerosis detected by multislice computed tomography and traditional risk-factor assessment","volume":"102","author":"Nair","year":"2008","journal-title":"Am J Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jacc.2015.10.058","article-title":"Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment","volume":"67","author":"Yeboah","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMoa021993","article-title":"Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events","volume":"347","author":"Ridker","year":"2002","journal-title":"N Engl J Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1056\/NEJMoa072100","article-title":"Coronary calcium as a predictor of coronary events in four racial or ethnic groups","volume":"358","author":"Detrano","year":"2008","journal-title":"N Engl J Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11883-016-0565-6","article-title":"An update on the utility of coronary artery calcium scoring for coronary heart disease and cardiovascular disease risk prediction","volume":"18","author":"Kianoush","year":"2016","journal-title":"Curr Atheroscler Rep."},{"key":"B39","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.rec.2013.04.009","article-title":"Proteomics and metabolomics for mechanistic insights and biomarker discovery in cardiovascular disease","volume":"66","author":"Barallobre-Barreiro","year":"2013","journal-title":"Rev Espa\u00f1ola Cardiol English Ed."},{"key":"B40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11883-010-0110-y","article-title":"Lipidomics: a tool for studies of atherosclerosis","volume":"12","author":"Ekroos","year":"2010","journal-title":"Curr Atheroscler Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e000032","DOI":"10.1161\/HCG.0000000000000032","article-title":"Potential impact and study considerations of metabolomics in cardiovascular health and disease","volume":"10","author":"Cheng","year":"2017","journal-title":"Circ Cardiovasc Genet."},{"key":"B42","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.redox.2017.04.032","article-title":"Comprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseases","volume":"12","author":"Lu","year":"2017","journal-title":"Redox Biol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/CIRCGENETICS.109.852814","article-title":"Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events","volume":"3","author":"Shah","year":"2010","journal-title":"Circ Cardiovasc Genet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/j.jacc.2009.02.036","article-title":"Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk","volume":"53","author":"Tang","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1161\/ATVBAHA.111.234096","article-title":"Plasma lipidomic analysis of stable and unstable coronary artery disease","volume":"31","author":"Meikle","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.bbrc.2018.04.106","article-title":"Lipidomic insight into cardiovascular diseases","volume":"504","author":"Kohno","year":"2018","journal-title":"Biochem Biophys Res Commun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/cvr\/cvs191","article-title":"Cardiac-generated prostanoids mediate cardiac myocyte apoptosis after myocardial ischaemia","volume":"95","author":"Qiu","year":"2012","journal-title":"Cardiovasc Res."},{"key":"B48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11306-017-1202-2","article-title":"Untargeted metabolomics reveals a mild impact of remote ischemic conditioning on the plasma metabolome and \u03b1-hydroxybutyrate as a possible cardioprotective factor and biomarker of tissue ischemia","volume":"13","author":"Laursen","year":"2017","journal-title":"Metabolomics."},{"key":"B49","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.yjmcc.2009.08.017","article-title":"Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: insight gained using metabolomic approaches","volume":"47","author":"Li","year":"2009","journal-title":"J Mol Cell Cardiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.pcad.2012.06.004","article-title":"Translating metabolomics to cardiovascular biomarkers","volume":"55","author":"Senn","year":"2012","journal-title":"Prog Cardiovasc Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s11306-013-0595-9","article-title":"Plasma metabolomics reveals a potential panel of biomarkers for early diagnosis in acute coronary syndrome","volume":"10","author":"Laborde","year":"2014","journal-title":"Metabolomics."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.jacc.2015.02.018","article-title":"Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure","volume":"65","author":"Cheng","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"36359","DOI":"10.1038\/srep36359","article-title":"A comparative metabolomics approach reveals early biomarkers for metabolic response to acute myocardial infarction","volume":"6","author":"Ali","year":"2016","journal-title":"Sci Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.114.013116","article-title":"Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts","volume":"131","author":"W\u00fcrtz","year":"2015","journal-title":"Circulation."},{"key":"B55","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/ejhf.1076","article-title":"Nuclear magnetic resonance-based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation: results from PROSPER and FINRISK 1997","volume":"20","author":"Delles","year":"2018","journal-title":"Eur J Heart Fail."},{"key":"B56","doi-asserted-by":"publisher","first-page":"570628","DOI":"10.3389\/fendo.2020.570628","article-title":"Ceramides and ceramide scores: clinical applications for cardiometabolic risk stratification","volume":"11","author":"Hilvo","year":"2020","journal-title":"Front Endocrinol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/eurheartj\/ehz387","article-title":"Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients","volume":"41","author":"Hilvo","year":"2019","journal-title":"Eur Heart J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis \u2014 an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1161\/CIRCRESAHA.114.302699","article-title":"Inflammation and its resolution as determinants of acute coronary syndromes","volume":"114","author":"Libby","year":"2014","journal-title":"Circ Res."},{"key":"B61","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","article-title":"Triglycerides and cardiovascular disease","volume":"384","author":"Nordestgaard","year":"2014","journal-title":"Lancet."},{"key":"B62","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41569-021-00582-9","article-title":"Effects of fatty acids on T cell function: role in atherosclerosis","volume":"18","author":"Reilly","year":"2021","journal-title":"Nat Rev Cardiol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1093\/eurheartj\/ehx786","article-title":"Plaque erosion: a new in vivo diagnosis and a potential major shift in the management of patients with acute coronary syndromes","volume":"39","author":"Partida","year":"2018","journal-title":"Eur Heart J."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3390\/nu10101398","article-title":"Implication of trimethylamine N-oxide (TMAO) in disease: potential biomarker or new therapeutic target","volume":"10","author":"Janeiro","year":"2018","journal-title":"Nutrients."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N Engl J Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature."},{"key":"B67","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/jcmm.13307","article-title":"Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies","volume":"22","author":"Qi","year":"2018","journal-title":"J Cell Mol Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1161\/CIRCGENETICS.114.000219","article-title":"Does our gut microbiome predict cardiovascular risk?","volume":"8","author":"Griffin","year":"2015","journal-title":"Circ Cardiovasc Genet."},{"key":"B69","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2105\/AJPH.41.3.279","article-title":"Epidemiological approaches to heart disease: the Framingham Study","volume":"41","author":"Dawber","year":"1951","journal-title":"Am J Public Heal Nations Heal."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1161\/CIR.0000000000000624","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jacc.2009.07.020","article-title":"Value and limitations of existing scores for the assessment of cardiovascular risk","volume":"54","author":"Cooney","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1161\/01.ATV.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"24","author":"Grundy","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0828-282X(09)70715-9","article-title":"2009 Canadian Cardiovascular Society\/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult \u2013 2009 recommendations","volume":"25","author":"Genest","year":"2009","journal-title":"Can J Cardiol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MCA.0b013e3283511608","article-title":"Cardiovascular risk and coronary atherosclerotic plaques detected by multidetector computed tomography","volume":"23","author":"Canpolat","year":"2012","journal-title":"Coron Artery Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA Guideline on the assessment of cardiovascular risk","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1161\/HYP.0000000000000065","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension."},{"key":"B78","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1093\/eurheartj\/ehab312","article-title":"SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions","volume":"42","author":"de Vries","year":"2021","journal-title":"Eur Heart J."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"Hageman","year":"2021","journal-title":"Eur Heart J."},{"key":"B80","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women","volume":"297","author":"Ridker","year":"2007","journal-title":"JAMA."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.108.814251","article-title":"C-reactive protein and parental history improve global cardiovascular risk prediction","volume":"118","author":"Ridker","year":"2008","journal-title":"Circulation."},{"key":"B82","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1161\/CIRCOUTCOMES.108.831198","article-title":"C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study","volume":"1","author":"Wilson","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes."},{"key":"B83","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/1354750X.2020.1716073","article-title":"Predictive value of metabolomic biomarkers for cardiovascular disease risk: a systematic review and meta-analysis","volume":"25","author":"McGranaghan","year":"2020","journal-title":"Biomarkers."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.jacc.2006.10.079","article-title":"Long-term prognosis associated with coronary calcification","volume":"49","author":"Budoff","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J Am Coll Cardiol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1093\/eurheartj\/ehy217","article-title":"Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"39","author":"Budoff","year":"2018","journal-title":"Eur Heart J."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e197440","DOI":"10.1001\/jamanetworkopen.2019.7440","article-title":"Association of coronary artery calcium with long-term, cause-specific mortality among young adults","volume":"2","author":"Miedema","year":"2019","journal-title":"JAMA Netw Open."},{"key":"B88","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ijcard.2016.12.068","article-title":"Using coronary calcification to exclude an ischemic etiology for cardiomyopathy: a validation study and systematic review","volume":"230","author":"Premaratne","year":"2017","journal-title":"Int J Cardiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jcmg.2017.05.007","article-title":"Coronary artery calcium scoring","volume":"10","author":"Blaha","year":"2017","journal-title":"JACC Cardiovasc Imaging."},{"key":"B90","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2014.12.040","article-title":"Scoring of coronary artery calcium scans: history, assumptions, current limitations, and future directions","volume":"239","author":"Alluri","year":"2015","journal-title":"Atherosclerosis."},{"key":"B91","doi-asserted-by":"publisher","first-page":"214","DOI":"10.21037\/cdt.2019.04.05","article-title":"Reclassification of coronary heart disease risk in a primary prevention setting: traditional risk factor assessment vs. coronary artery calcium scoring","volume":"9","author":"Alashi","year":"2019","journal-title":"Cardiovasc Diagn Ther."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1093\/eurheartj\/eht508","article-title":"Impact of coronary artery calcium on coronary heart disease events in individuals at the extremes of traditional risk factor burden: the multi-ethnic study of atherosclerosis","volume":"35","author":"Silverman","year":"2014","journal-title":"Eur Heart J."},{"key":"B93","doi-asserted-by":"publisher","first-page":"357","DOI":"10.5694\/mja16.01134","article-title":"Cardiac Society of Australia and New Zealand position statement executive summary: coronary artery calcium scoring","volume":"207","author":"Hamilton-Craig","year":"2017","journal-title":"Med J Aust."},{"key":"B94","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jacc.2019.05.032","article-title":"Coronary artery calcium scores of zero and establishing the concept of negative risk factors","volume":"74","author":"Blaha","year":"2019","journal-title":"J Am Coll Cardiol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.atherosclerosis.2019.11.008","article-title":"All-cause and cause-specific mortality in individuals with zero and minimal coronary artery calcium: a long-term, competing risk analysis in the Coronary Artery Calcium Consortium","volume":"294","author":"Blaha","year":"2019","journal-title":"Atherosclerosis."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.08.001","article-title":"Identification and visualization of oxidized lipids in atherosclerotic plaques by microscopic imaging mass spectrometry-based metabolomics","volume":"311","author":"Shen","year":"2020","journal-title":"Atherosclerosis."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1021\/pr5009898","article-title":"Metabolic phenotyping of atherosclerotic plaques reveals latent associations between free cholesterol and ceramide metabolism in atherogenesis","volume":"14","author":"Vorkas","year":"2015","journal-title":"J Proteome Res."},{"key":"B98","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2017.11.034","article-title":"Metabolic phenotyping of human atherosclerotic plaques: metabolic alterations and their biological relevance in plaque-containing aorta","volume":"269","author":"Jung","year":"2018","journal-title":"Atherosclerosis."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0195-668X(03)00280-X","article-title":"Detection of exercise induced ischaemia: a new role for cardiopulmonary exercise testing [editorial]","volume":"24","author":"Schmid","year":"2003","journal-title":"Eur Heart J."},{"key":"B100","first-page":"293","article-title":"Exercise stress testing: indications and common questions","volume":"96","author":"Garner","year":"2017","journal-title":"Am Fam Physician."},{"key":"B101","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1161\/CIRCULATIONAHA.105.166543","article-title":"Exercise testing in asymptomatic adults","volume":"112","author":"Lauer","year":"2005","journal-title":"Circulation."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1161\/01.CIR.0000143226.40607.71","article-title":"Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham Risk Score","volume":"110","author":"Balady","year":"2004","journal-title":"Circulation."},{"key":"B103","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1161\/CIRCULATIONAHA.111.041293","article-title":"Using stress testing to guide primary prevention of coronary heart disease among intermediate-risk patients","volume":"125","author":"Galper","year":"2012","journal-title":"Circulation."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2009.476","article-title":"Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes","volume":"301","author":"Young","year":"2009","journal-title":"JAMA."},{"key":"B105","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12872-016-0256-9","article-title":"Screening for asymptomatic coronary artery disease in patients with diabetes mellitus: a systematic review and meta-analysis of randomized trials","volume":"16","author":"Bauters","year":"2016","journal-title":"BMC Cardiovasc Disord."},{"key":"B106","doi-asserted-by":"publisher","first-page":"W9","DOI":"10.7326\/0003-4819-140-7-200404060-w1","article-title":"Exercise tolerance testing to screen for coronary heart disease: a systematic review for the technical support for the US Preventive Services Task Force","volume":"140","author":"Fowler-Brown","year":"2004","journal-title":"Ann Intern Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1161\/CIRCULATIONAHA.105.569137","article-title":"Metabolomic identification of novel biomarkers of myocardial ischemia","volume":"112","author":"Sabatine","year":"2005","journal-title":"Circulation."},{"key":"B108","doi-asserted-by":"publisher","first-page":"e0211762","DOI":"10.1371\/journal.pone.0211762","article-title":"Pilot study of myocardial ischemia-induced metabolomic changes in emergency department patients undergoing stress testing","volume":"14","author":"Limkakeng","year":"2019","journal-title":"PLoS ONE."},{"key":"B109","doi-asserted-by":"publisher","first-page":"17838","DOI":"10.1038\/s41598-020-74880-6","article-title":"1H NMR serum metabolomic profiling of patients at risk of cardiovascular diseases performing stress test","volume":"10","author":"Lema","year":"2020","journal-title":"Sci Rep."},{"key":"B110","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10554-015-0741-8","article-title":"Plaque assessment by coronary CT","volume":"32","author":"Szilveszter","year":"2016","journal-title":"Int J Cardiovasc Imaging."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1161\/ATVBAHA.108.179739","article-title":"Concept of vulnerable\/unstable plaque","volume":"30","author":"Finn A","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1016\/j.amjcard.2011.02.337","article-title":"Positive remodeling on coronary computed tomography as a marker for plaque vulnerability on virtual histology intravascular ultrasound","volume":"107","author":"Kr\u00f6ner","year":"2011","journal-title":"Am J Cardiol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jcmg.2012.03.019","article-title":"The napkin-ring sign indicates advanced atherosclerotic lesions in coronary CT angiography","volume":"5","author":"Maurovich-Horvat","year":"2012","journal-title":"JACC Cardiovasc Imaging."},{"key":"B114","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.jacc.2007.03.044","article-title":"Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes","volume":"50","author":"Motoyama","year":"2007","journal-title":"J Am Coll Cardiol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2010.12.006","article-title":"In vivo CT detection of lipid-rich coronary artery atherosclerotic plaques using quantitative histogram analysis: a head to head comparison with IVUS","volume":"215","author":"Marwan","year":"2011","journal-title":"Atherosclerosis."},{"key":"B116","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2459\/JCM.0b013e3283403955","article-title":"Assessment of coronary stenosis, plaque burden and remodeling by multidetector computed tomography in patients referred for suspected coronary artery disease","volume":"12","author":"Pedrazzini","year":"2011","journal-title":"J Cardiovasc Med."},{"key":"B117","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jcmg.2012.09.016","article-title":"Napkin-ring sign on coronary CT angiography for the prediction of acute coronary syndrome","volume":"6","author":"Otsuka","year":"2013","journal-title":"JACC Cardiovasc Imaging."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.jacc.2010.07.005","article-title":"ACCF\/SCCT\/ACR\/AHA\/ASE\/ASNC\/NASCI\/SCAI\/SCMR 2010 Appropriate use criteria for cardiac computed tomography","volume":"56","author":"Taylor","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/ehjci\/jet148","article-title":"Does coronary CT angiography improve risk stratification over coronary calcium scoring in symptomatic patients with suspected coronary artery disease? Results from the prospective multicenter international CONFIRM registry","volume":"15","author":"Al-Mallah","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"B120","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jcmg.2017.08.026","article-title":"The Coronary Artery Disease - Reporting and Data System (CAD-RADS)","volume":"11","author":"Xie","year":"2018","journal-title":"JACC Cardiovasc Imaging."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s10554-013-0232-8","article-title":"Coronary computed tomography angiography-adapted Leaman score as a tool to noninvasively quantify total coronary atherosclerotic burden","volume":"29","author":"Gon\u00e7alves","year":"2013","journal-title":"Int J Cardiovasc Imaging."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/j.jcmg.2018.10.024","article-title":"Superior risk stratification with coronary computed tomography angiography using a comprehensive atherosclerotic risk score","volume":"12","author":"van Rosendael","year":"2019","journal-title":"JACC Cardiovasc Imaging."},{"key":"B123","doi-asserted-by":"publisher","first-page":"e002332","DOI":"10.1161\/CIRCIMAGING.114.002332","article-title":"Long-term prognostic effect of coronary atherosclerotic burden","volume":"8","author":"Mushtaq","year":"2015","journal-title":"Circ Cardiovasc Imaging."},{"key":"B124","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijcard.2016.12.137","article-title":"Long-term prognostic impact of CT-Leaman score in patients with non-obstructive CAD: results from the Coronary CT Angiography Evaluation For Clinical Outcomes International Multicenter (CONFIRM) study","volume":"231","author":"Andreini","year":"2017","journal-title":"Int J Cardiol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1161\/CIRCULATIONAHA.109.912568","article-title":"Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction","volume":"123","author":"Wang","year":"2011","journal-title":"Circulation."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1001\/archinte.166.13.1368","article-title":"An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers","volume":"166","author":"Folsom","year":"2006","journal-title":"Arch Intern Med."},{"key":"B127","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jama.2009.943","article-title":"Novel and conventional biomarkers for prediction of incident cardiovascular events in the community","volume":"302","author":"Melander","year":"2009","journal-title":"JAMA."},{"key":"B128","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.jacc.2016.05.084","article-title":"simple disease-guided approach to personalize ACC\/AHA-recommended statin allocation in elderly people","volume":"68","author":"Mortensen","year":"2016","journal-title":"J Am Coll Cardiol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis","volume":"54","author":"Libby","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J."},{"key":"B131","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/jama.290.7.898","article-title":"Prevalence of conventional risk factors in patients with coronary heart disease","volume":"290","author":"Khot","year":"2003","journal-title":"JAMA."},{"key":"B132","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1001\/2012.jama.10456","article-title":"Cardiovascular risk assessment in the 21st century [editorial]","volume":"308","author":"Gaziano","year":"2012","journal-title":"JAMA."},{"key":"B133","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/S0735-1097(02)02017-X","article-title":"Contribution of major cardiovascular risk factors to familial premature coronary artery disease","volume":"40","author":"Jomini","year":"2002","journal-title":"J Am Coll Cardiol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40169-018-0182-9","article-title":"Lipidomics unveils the complexity of the lipidome in metabolic diseases","volume":"7","author":"Lydic","year":"2018","journal-title":"Clin Transl Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ahj.2008.08.010","article-title":"Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines","volume":"157","author":"Sachdeva","year":"2009","journal-title":"Am Heart J."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.jacc.2015.02.020","article-title":"Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 \u00d7 2 factorial Mendelian randomization study","volume":"65","author":"Ference","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jacc.2012.08.1026","article-title":"Remnant cholesterol as a causal risk factor for ischemic heart disease","volume":"61","author":"Varbo","year":"2013","journal-title":"J Am Coll Cardiol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"8973","DOI":"10.2147\/IJN.S223524","article-title":"Variable effects of LDL subclasses of cholesterol on endothelial nitric oxide\/peroxynitrite balance \u2013 the risks and clinical implications for cardiovascular disease","volume":"14","author":"Hua","year":"2019","journal-title":"Int J Nanomedicine."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/ATVBAHA.114.303284","article-title":"Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease","volume":"34","author":"Hoogeveen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"457960","DOI":"10.1101\/457960","article-title":"Genetics of human plasma lipidome: understanding lipid metabolism and its link to diseases beyond traditional lipids","volume":"10","author":"Tabassum","year":"2018","journal-title":"bioRxiv."},{"key":"B141","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1177\/1741826711410821","article-title":"Asymmetrical distribution of atherosclerosis in the carotid artery: identical patterns across age, race, and gender","volume":"19","author":"Tajik","year":"2012","journal-title":"Eur J Prev Cardiol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/oxfordjournals.aje.a009302","article-title":"Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study, 1987-1993","volume":"146","author":"Chambless","year":"1997","journal-title":"Am J Epidemiol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4103\/0366-6999.173500","article-title":"Carotid intima-media thickness measurements: relations with atherosclerosis, risk of cardiovascular disease and application in randomized controlled trials","volume":"129","author":"Bots","year":"2016","journal-title":"Chin Med J."},{"key":"B144","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejvs.2014.04.026","article-title":"Carotid intima-media thickness and\/or carotid plaque: what is relevant?","volume":"48","author":"Sillesen","year":"2014","journal-title":"Eur J Vasc Endovasc Surg."},{"key":"B145","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.2337\/dc11-0816","article-title":"Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis","volume":"34","author":"Malik","year":"2011","journal-title":"Diabetes Care."},{"key":"B146","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1001\/jama.2012.9630","article-title":"Common carotid intima-media thickness measurements in cardiovascular risk prediction","volume":"308","author":"Den Ruijter","year":"2012","journal-title":"JAMA."},{"key":"B147","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ihj.2018.01.010","article-title":"The association between increased carotid intima\u2013media thickness and SYNTAX score in coronary artery disease: a single center study","volume":"70","author":"Saedi","year":"2018","journal-title":"Indian Heart J."},{"key":"B148","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMra072149","article-title":"Computed tomography \u2014 an increasing source of radiation exposure","volume":"357","author":"Brenner","year":"2007","journal-title":"N Engl J Med."},{"key":"B149","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1161\/CIRCULATIONAHA.117.031178","article-title":"Computed tomography or functional stress testing for the prediction of risk [editorial]","volume":"136","author":"Newby","year":"2017","journal-title":"Circulation."},{"key":"B150","doi-asserted-by":"publisher","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","article-title":"Pathology of the vulnerable plaque","volume":"47","author":"Virmani","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1148\/radiol.14140066","article-title":"Coronary artery calcification scoring with state-of-the-art CT scanners from different vendors has substantial effect on risk classification","volume":"273","author":"Willemink","year":"2014","journal-title":"Radiology."},{"key":"B152","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1161\/CIRCIMAGING.113.000341","article-title":"Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease?","volume":"7","author":"Blaha","year":"2014","journal-title":"Circ Cardiovasc Imaging."},{"key":"B153","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41569-020-00477-1","article-title":"Systems biology in cardiovascular disease: a multiomics approach","volume":"18","author":"Joshi","year":"2021","journal-title":"Nat Rev Cardiol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1172\/JCI86924","article-title":"Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques","volume":"127","author":"Langley","year":"2017","journal-title":"J Clin Invest."},{"key":"B155","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.2174\/1385272817888131118162725","article-title":"The role of mass spectrometry in the omics era","volume":"17","author":"Girolamo","year":"2013","journal-title":"Curr Org Chem."},{"key":"B156","first-page":"1","article-title":"What are omics sciences?","volume-title":"Periparturient Diseases of Dairy Cows.","author":"Vailati-Riboni","year":"2017"},{"key":"B157","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11883-010-0112-9","article-title":"Metabolomics and atherosclerosis","volume":"12","author":"Goonewardena","year":"2010","journal-title":"Curr Atheroscler Rep."},{"key":"B158","doi-asserted-by":"publisher","first-page":"75","DOI":"10.21577\/0100-4042.20170134","article-title":"Metabolomics: definitions, state-of-the-art and representative applications","volume":"41","author":"Canuto","year":"2017","journal-title":"Quim Nova."},{"key":"B159","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/978-94-010-0448-0_11","article-title":"Metabolomics - the link between genotypes and phenotypes","volume":"48","author":"Fiehn","year":"2002","journal-title":"Plant Mol Biol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/mas.20108","article-title":"Mass spectrometry-based metabolomics","volume":"26","author":"Dettmer","year":"2007","journal-title":"Mass Spectrom Rev."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/4551054a","article-title":"Metabonomics","volume":"455","author":"Nicholson","year":"2008","journal-title":"Nature."},{"key":"B162","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1080\/004982599238047","article-title":"Metabonomics\u201d: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data","volume":"29","author":"Nicholson","year":"1999","journal-title":"Xenobiotica."},{"key":"B163","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-47656-8_1","article-title":"Metabolomics: definitions and significance in systems biology","volume-title":"Metabolomics: From Fundamentals to Clinical Applications. Advances in Experimental Medicine and Biology","author":"Klassen","year":"2017"},{"key":"B164","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-319-47656-8_5","article-title":"Strategies involving mass spectrometry combined with capillary electrophoresis in metabolomics","volume-title":"Metabolomics: From Fundamentals to Clinical Applications. Advances in Experimental Medicine and Biology","author":"Rodrigues","year":"2017"},{"key":"B165","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.clinbiochem.2020.03.004","article-title":"After another decade: LC\u2013MS\/MS became routine in clinical diagnostics","volume":"82","author":"Seger","year":"2020","journal-title":"Clin Biochem."},{"key":"B166","first-page":"1","article-title":"Mass spectrometry for the clinical laboratory: determining the need and avoiding pitfalls","volume-title":"Mass Spectrometry for the Clinical Laboratory","author":"Clarke","year":"2016"},{"key":"B167","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/jclinpath-2019-206269","article-title":"Emerging role of clinical mass spectrometry in pathology","volume":"73","author":"Fung","year":"2020","journal-title":"J Clin Pathol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jsbmb.2010.02.017","article-title":"Clinical steroid mass spectrometry: a 45-year history culminating in HPLC\u2013MS\/MS becoming an essential tool for patient diagnosis","volume":"121","author":"Shackleton","year":"2010","journal-title":"J Steroid Biochem Mol Biol."},{"key":"B169","first-page":"264","article-title":"Recent advances in the clinical application of mass spectrometry [editorial]","volume":"27","author":"Greaves","year":"2016","journal-title":"J Int Fed Clin Chem Lab Med."},{"key":"B170","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1373\/clinchem.2015.238626","article-title":"CLSI C62-A: a new standard for clinical mass spectrometry","volume":"62","author":"Lynch","year":"2016","journal-title":"Clin Chem."},{"key":"B171","doi-asserted-by":"publisher","first-page":"2","DOI":"10.24508\/mms.2019.06.005","article-title":"Applications of mass spectrometry in clinical chemistry","volume":"3","author":"Satoh","year":"2019","journal-title":"Med Mass Spectrom."},{"key":"B172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-3182-8_1","article-title":"Mass spectrometry in clinical laboratory: applications in biomolecular analysis","volume-title":"Clinical Applications of Mass Spectrometry in Biomolecular Analysis. Methods in Molecular Biology","author":"Garg","year":"2016"},{"key":"B173","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ahj.2012.02.005","article-title":"Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease","volume":"163","author":"Shah","year":"2012","journal-title":"Am Heart J."},{"key":"B174","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","article-title":"Inflammation in atherosclerosis","volume":"32","author":"Libby","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10654-017-0333-0","article-title":"Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two german prospective cohorts","volume":"33","author":"Floegel","year":"2018","journal-title":"Eur J Epidemiol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.117.029468","article-title":"Metabolic predictors of incident coronary heart disease in women","volume":"137","author":"Paynter","year":"2018","journal-title":"Circulation."},{"key":"B177","doi-asserted-by":"publisher","first-page":"e1004801","DOI":"10.1371\/journal.pgen.1004801","article-title":"Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease","volume":"10","author":"Ganna","year":"2014","journal-title":"PLoS Genet."},{"key":"B178","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.atherosclerosis.2013.10.029","article-title":"Metabolomics signature improves the prediction of cardiovascular events in elderly subjects","volume":"232","author":"Rizza","year":"2014","journal-title":"Atherosclerosis."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet."},{"key":"B180","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1161\/CIRCULATIONAHA.118.034942","article-title":"Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatment","volume":"138","author":"Sliz","year":"2018","journal-title":"Circulation."},{"key":"B181","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1161\/ATVBAHA.116.307497","article-title":"Circulating ceramides predict cardiovascular outcomes in the population-based FINRISK 2002 cohort","volume":"36","author":"Havulinna","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B182","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","article-title":"Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol","volume":"37","author":"Laaksonen","year":"2016","journal-title":"Eur Heart J."},{"key":"B183","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1093\/eurheartj\/ehz252","article-title":"Atherosclerotic metabolites: basic science is progressing, so we need to think about clinical implications [editorial]","volume":"40","author":"Tillmann","year":"2019","journal-title":"Eur Heart J."},{"key":"B184","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1479-5876-2-44","article-title":"From bench to clinic and back: perspective on the 1st IQPC Translational Research conference","volume":"2","author":"H\u00f6rig","year":"2004","journal-title":"J Transl Med."},{"key":"B185","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1373\/clinchem.2015.248146","article-title":"Effective use of mass spectrometry in the clinical laboratory","volume":"62","author":"Jannetto","year":"2016","journal-title":"Clin Chem."},{"key":"B186","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1161\/CIR.0000000000000226","article-title":"Transformative impact of proteomics on cardiovascular health and disease","volume":"132","author":"Lindsey","year":"2015","journal-title":"Circulation."},{"key":"B187","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5339\/gcsp.2015.25","article-title":"Utility of mass spectrometry for the diagnosis of the unstable coronary plaque","volume":"2015","author":"Jacob","year":"2015","journal-title":"Glob Cardiol Sci Pract."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.788062\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T08:00:40Z","timestamp":1640160040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.788062\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,22]]},"references-count":187,"alternative-id":["10.3389\/fcvm.2021.788062"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.788062","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,22]]},"article-number":"788062"}}